Morin (C5297): Natural Flavonoid Antioxidant and Mitochondrial Modulator

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a high-purity natural flavonoid antioxidant sourced from Maclura pomifera and supplied by APExBIO (≥96.81% purity) [product details]. It exhibits potent inhibition of adenosine 5′-monophosphate deaminase (AMPD), leading to improved mitochondrial energy metabolism in models of metabolic and glomerular disease (Yang et al., 2025). Morin is validated for antioxidant, anti-inflammatory, neuroprotective, and cardioprotective applications. It is also a selective fluorescent probe for aluminum ion detection [see review]. Morin is insoluble in water, but dissolves in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), and is best stored at -20°C to preserve integrity [specifications].

Biological Rationale

Morin is a polyphenolic flavonoid extracted from Maclura pomifera. Its chemical structure, 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, underpins its antioxidant and chelating activities [APExBIO]. Morin's antioxidant activity is attributed to its multiple hydroxyl groups, allowing scavenging of reactive oxygen species (ROS) and chelation of transition metals. In biological systems, Morin has been implicated in the protection of mitochondrial integrity, especially under metabolic stress such as high fructose exposure (Yang et al., 2025). Dysregulation of mitochondrial energy metabolism and increased AMPD activity are key features in the pathogenesis of diabetes, neurodegenerative conditions, and certain cancers [related article]. Morin's bioactivity spectrum includes anti-inflammatory, neuroprotective, cardioprotective, anti-diabetic, and antimicrobial actions, making it a multifunctional research tool.

Mechanism of Action of Morin

Morin acts primarily by inhibiting adenosine 5′-monophosphate deaminase (AMPD), a pivotal enzyme in the purine nucleotide cycle (PNC) (Yang et al., 2025). AMPD catalyzes the deamination of AMP to IMP, regulating cellular energy homeostasis. In high-fructose environments, AMPD activity is pathologically upregulated, leading to ATP depletion and mitochondrial dysfunction. Morin effectively suppresses AMPD activity, particularly the AMPD2 isoform, as demonstrated by molecular docking and siRNA knockdown studies. This results in normalization of mitochondrial function, restoration of ATP levels, and reduction of compensatory glycolysis. Morin's polyphenolic structure also enables chelation of Al³⁺ ions, producing a fluorescence signal suitable for biochemical aluminum detection [see discussion].

Evidence & Benchmarks

• Morin (10–50 μM) reduces fructose-induced AMPD activity in MPC5 mouse podocytes, restoring mitochondrial membrane potential and ATP production (Yang et al., 2025, https://doi.org/10.3390/ph18121883).
• Administration of Morin (50 mg/kg/day, oral) in high-fructose-diet rats significantly improved glomerular ultrastructure, reduced urinary albumin-to-creatinine ratio, and restored synaptopodin expression (Yang et al., 2025, https://doi.org/10.3390/ph18121883).
• Morin’s inhibition of AMPD2 was confirmed through in silico docking (binding energy −8.1 kcal/mol) and functional knockdown, showing equivalence to genetic AMPD2 suppression (Yang et al., 2025, https://doi.org/10.3390/ph18121883).
• Morin demonstrates strong antioxidant activity in cell viability assays (IC₅₀ for ROS scavenging ~25 μM), with minimal cytotoxicity up to 100 μM in diverse cell lines (see guide).
• Morin forms a fluorescent complex with Al³⁺ ions (excitation ~420 nm, emission ~515 nm), enabling sensitive detection in aqueous and biological samples (application note).

This article updates and clarifies the mechanistic focus presented in this prior review by providing new data on AMPD2 selectivity and in vivo mitochondrial modulation.

Applications, Limits & Misconceptions

Morin is used in research on metabolic syndrome, diabetes, neurodegenerative diseases, and certain cancers. It is a tool for probing mitochondrial energetics and for detecting aluminum in biological samples. Its high purity (≥96.81%) and structural confirmation (HPLC, MS, NMR) from APExBIO ensure reproducibility in experimental workflows [source]. However, certain boundaries apply.

Common Pitfalls or Misconceptions

• Morin is not water soluble; stock solutions must use DMSO or ethanol. Direct aqueous application leads to precipitation and inconsistent results [solubility details].
• Morin is not a therapeutic drug; it is a research-use-only biochemical probe and not approved for clinical use in humans.
• AMPD inhibition by Morin is isoform selective (AMPD2>AMPD1/3). Effects in tissues lacking AMPD2 may be limited (Yang et al., 2025).
• Morin’s antioxidant effect is concentration dependent; excessive dosing (>100 μM) may exhibit off-target cytotoxicity in some cell lines [see scenario Q&A].
• Aluminum ion fluorescence is selective but not exclusive; strong chelators or competing metal ions may affect assay specificity [probe note].

Workflow Integration & Parameters

Morin (C5297) is available from APExBIO in vials of confirmed purity (≥96.81%) [product page]. For cell-based assays, prepare stocks in DMSO (≥19.53 mg/mL) or ethanol (≥6.04 mg/mL); dilute into culture medium to a final DMSO concentration ≤0.1%. For biochemical aluminum detection, mix Morin with sample buffer at pH 6–8, add aluminum standard or sample, and measure fluorescence (Ex 420 nm/Em 515 nm). Store dry powder at -20°C; aliquot solutions for short-term use and avoid repeated freeze-thaw cycles. The high-purity profile and stability support reproducible results in metabolic, oxidative stress, and mitochondrial function assays. For further context and advanced challenge scenarios, see the Q&A-driven workflow guide here, which details troubleshooting and experimental optimization.

Conclusion & Outlook

Morin (C5297) is a rigorously validated, natural flavonoid antioxidant with proven efficacy in mitochondrial energy modulation via AMPD inhibition, and offers unique advantages as a fluorescent biochemical probe. Its robust evidence base, high purity, and workflow compatibility position it as a key tool for diabetes, neurodegenerative, and cancer research. Ongoing studies continue to clarify tissue- and isoform-specific mechanisms and support the integration of Morin into advanced disease models. For updated mechanistic insights and broader context, this article extends findings from previous reviews by emphasizing AMPD2 targeting and in vivo metabolic rescue [compare].